The European Union is pivoting to the Pfizer/BioNTech coronavirus shot with a record agreement to buy up to 1.8 billion doses, as court proceedings in its lawsuit against another major vaccine maker, AstraZeneca, began in Brussels on Wednesday.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.